Navigation Links
CryoLife Begins Distribution of Blood-Clotting Agent PerClot® in Europe
Date:10/25/2010

ATLANTA, Oct. 25 /PRNewswire/ --  CryoLife, Inc. (NYSE: CRY), an implantable biological medical device and cardiovascular tissue processing company, announced today that it has begun European distribution of PerClot®, a novel polysaccharide hemostatic agent used to control bleeding during surgical procedures or following traumatic injuries.

"PerClot is an exciting technology platform that has seen success in Europe already, and we are pleased to begin offering this product in France," stated Steven G. Anderson, CryoLife president and chief executive officer.  "Our international and largely unrestricted distribution agreement allows us to address a very broad range of medical specialties in the growing hemostatic agent market.  We look forward to expanding distribution within the European Union and many other markets around the world in the coming months."

The European hemostatic market is estimated to be $279 million in 2010 growing to approximately $430 million in 2014.(1)

On September 28, 2010, CryoLife entered into a worldwide distribution agreement and a manufacturing agreement with Starch Medical Inc. (SMI) of San Jose, California for PerClot, a unique, absorbable powder hemostat that has CE Mark designation allowing commercial distribution into the European Community and other markets.  PerClot is indicated for use in surgical procedures, including cardiac, vascular, orthopedic, spinal, neurological, gynecological, ENT and trauma surgery as an adjunct hemostat when control of bleeding from capillary, venous, or arteriolar vessels by pressure, ligature, and other conventional means is either ineffective or impractical. 

CryoLife plans to file an Investigational Device Exemption (IDE) with the United States Food and Drug Administration (FDA) to begin clinical trials for the purpose of obtaining Pre-Market Approva
'/>"/>

SOURCE CryoLife, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. CryoLife Announces Release Date and Teleconference Call Details for 2010 Third Quarter Financial Results
2. CryoLife Receives Japanese Regulatory Approval for BioGlue Surgical Adhesive
3. CryoLife Enters into Worldwide Distribution and Manufacturing Agreements with Starch Medical for Novel Hemostatic Agent
4. CryoLife Provides Initial 2010 Financial Guidance
5. CryoLife to Present at 21st Annual Piper Jaffray Health Care Conference
6. CryoLife to Present at Upcoming Investor Conferences in New York
7. CryoLife Reports Record Quarterly Revenues of $28.2 Million
8. CryoLife Receives FDA Approval to Begin U.S. Clinical Trial for BioFoam(R)
9. CryoLife Announces First Implant of Combination Aortic-Mitral Allograft Heart Valve at the Cleveland Clinic
10. BiondVax Begins Phase IIa Study for Universal Flu Vaccine
11. LIG Assets, Inc. Begins Distribution and Marketing of Unique CPAP Mask Cleaner
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Asterias Biotherapeutics Inc. (OTCBB: ASTY) has received ... to initiate a Phase 1/2a clinical trial of its ... injury.  The approved trial follows the successful completion of ... is designed to assess safety and activity of escalating ... cord injuries, the first targeted indication for AST-OPC1 and ...
(Date:8/26/2014)... STATESVILLE, N.C., Aug. 26, 2014  Kewaunee Scientific Corporation ... its first quarter ended July 31, 2014. ... sales of $32,003,000 in the first quarter last year. ... per diluted share, as compared to net earnings of ... quarter of the prior year. However, both sales and ...
(Date:8/26/2014)... 26, 2014 Research and Markets ... Meter Industry Report 2014 " report to their ... Report 2014 is a professional and in-depth study on ... The report provides a basic overview of ... structure. The glucose meter market analysis is provided for ...
Breaking Medicine Technology:Asterias Biotherapeutics Receives U.S. FDA Clearance to Initiate Phase 1/2a Clinical Trial of AST-OPC1 in Patients with Cervical Complete Spinal Cord Injury 2Asterias Biotherapeutics Receives U.S. FDA Clearance to Initiate Phase 1/2a Clinical Trial of AST-OPC1 in Patients with Cervical Complete Spinal Cord Injury 3Asterias Biotherapeutics Receives U.S. FDA Clearance to Initiate Phase 1/2a Clinical Trial of AST-OPC1 in Patients with Cervical Complete Spinal Cord Injury 4Asterias Biotherapeutics Receives U.S. FDA Clearance to Initiate Phase 1/2a Clinical Trial of AST-OPC1 in Patients with Cervical Complete Spinal Cord Injury 5Kewaunee Scientific Reports Results for First Quarter 2Kewaunee Scientific Reports Results for First Quarter 3Kewaunee Scientific Reports Results for First Quarter 4Kewaunee Scientific Reports Results for First Quarter 5Kewaunee Scientific Reports Results for First Quarter 6Global Glucose Meter Industry Report 2014 2Global Glucose Meter Industry Report 2014 3
(Date:8/27/2014)... California and Ontario, Canada (PRWEB) August 27, 2014 ... going through a huge transformation as was revealed in ... this 2014 survey were not just surprising but astonishing ... The survey carried out online interviewed existing members on ... like Facebook. , According to Kaly, 10yeargap marketing department ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 Discover Leadership ... personal and corporate transformation through their comprehensive leadership programs. ... Moses has unparalleled experience in the realm of outcome-focused ... this expertise in a new webinar series titled, “A ... Seller.” The first of this two part webinar is ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 Overcoming a turbulent ... finally found his niche. The Women’s Radio Network, WRNW1, has ... his continued support and dedication to the WRNW1 family. KC ... to have such a positive atmosphere.” After KC Armstrong publicly ... XM of the Howard Stern show, “Howard 100 News,” have ...
(Date:8/27/2014)... Casey Diekman, assistant professor of mathematical sciences at ... gain greater insight into the biological clock that sets ... the behavior of humans and all other mammals with ... light and dark experienced each day and with seasonal ... to natural patterns of sleep/wake behavior which, when disrupted ...
(Date:8/27/2014)... President Obama is considering Executive action soon that ... initiative that supplies green cards and work - authorized ... a pathway to Social Security benefits, warns The ... authorization would add new long-term liabilities to Social Security ... of proposals to cut the growth in beneficiaries’ annual ...
Breaking Medicine News(10 mins):Health News:Survey Reveals Younger Women Dating Older Men 2Health News:Survey Reveals Younger Women Dating Older Men 3Health News:Barb Moses, Vice President of Discover Leadership Training, Announces New Webinar Titled, “A Women’s Guide to Making Her Life Story a Bestseller” 2Health News:The Women's Radio Network, WRNW1, Signs KC Armstrong to a Multi-Million Dollar Contract 2Health News:NJIT Researcher Receives New NSF Funding to Study Fundamental Rhythms of Life 2Health News:NJIT Researcher Receives New NSF Funding to Study Fundamental Rhythms of Life 3Health News:NJIT Researcher Receives New NSF Funding to Study Fundamental Rhythms of Life 4Health News:The Senior Citizens League (TSCL) Warns: White House Action On Immigration Could Give Social Security To Known Illegals 2
... comparison study finds chlorthalidone most likely to prevent ... News) -- Tried-and-true diuretics maintain their status as ... women with high blood pressure, new research concludes. ... treatments -- a calcium channel blocker, an ACE ...
... , Government Also Files Suit Against New York Hospital ... WASHINGTON, Nov. 18 The United States has entered into ... motion to intervene in a lawsuit against a New York ... Department announced today. , The United States settled ...
... Sinai School of Medicine set out to address a ... do dietary restrictionand the reverse, overconsumptionproduce protective effects against ... two-part study led by Charles Mobbs, PhD, Professor of ... Sinai School of Medicine, published in the November 17 ...
... ... and spa therapy for 30 years, has received the distinguished School of Excellence Award ... only ACCSC-accredited school in Massachusetts to receive this 2008-2009 Award. , ... Woburn, MA, November 18, 2009-- ...
... ... The Adaptive Business Leaders (ABL) Organization is asking for nominations for ... 12th Annual Innovations in Healthcare(SM) Awards Event, on April 28, 2010, in ... their value-driven approaches to solving some of the toughest problems facing healthcare ...
... MINEOLA, N.Y., Nov. 18 The United States Preventive ... a woman should be getting a mammography. The Maurer ... an official statement regarding her research and beliefs on ... Yesterday, The United States Preventive Services Task Force (USPSTF) ...
Cached Medicine News:Health News:Diuretics Still Best Treatment for High Blood Pressure 2Health News:New Jersey Hospital to Pay $3 Million to Resolve Allegations of Medicare Fraud 2Health News:Scientists find molecular trigger that helps prevent aging and disease 2Health News:Scientists find molecular trigger that helps prevent aging and disease 3Health News:ACCSC Grants Catherine Hinds Institute of Esthetics a Distinguished School of Excellence Award Award Recognizes High-Level Achievements of Students 2Health News:ACCSC Grants Catherine Hinds Institute of Esthetics a Distinguished School of Excellence Award Award Recognizes High-Level Achievements of Students 3Health News:Nominate Your Favorite Innovative Healthcare Company for the 2010 ABBY Awards 2Health News:Nominate Your Favorite Innovative Healthcare Company for the 2010 ABBY Awards 3Health News:Nominate Your Favorite Innovative Healthcare Company for the 2010 ABBY Awards 4Health News:Maurer Foundation for Breast Health Education Statement on USPSTF Guidelines for Mammography 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: